2006
DOI: 10.1038/nrc1804
|View full text |Cite
|
Sign up to set email alerts
|

Mapping normal and cancer cell signalling networks: towards single-cell proteomics

Abstract: Oncogenesis and tumour progression are supported by alterations in cell signalling. Using flow cytometry, it is now possible to track and analyse signalling events in individual cancer cells. Data from this type of analysis can be used to create a network map of signalling in each cell and to link specific signalling profiles with clinical outcomes. This form of 'single-cell proteomics' can identify pathways that are activated in therapy-resistant cells and can provide biomarkers for cancer diagnosis and for d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
229
0
2

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 295 publications
(233 citation statements)
references
References 87 publications
2
229
0
2
Order By: Relevance
“…In cancer patients, the possibility of detecting minimal residual disease (MRD) by sensitive molecular markers (for example, quantitative PCR) or other measures 93 is an important aspect of disease management. However, depending on the type of neoplasm, persistent MRD may not necessarily argue against long-term disease-free survival.…”
Section: Evaluation Of Csc Eradicationmentioning
confidence: 99%
“…In cancer patients, the possibility of detecting minimal residual disease (MRD) by sensitive molecular markers (for example, quantitative PCR) or other measures 93 is an important aspect of disease management. However, depending on the type of neoplasm, persistent MRD may not necessarily argue against long-term disease-free survival.…”
Section: Evaluation Of Csc Eradicationmentioning
confidence: 99%
“…Although flow cytometry initially allowed the investigation of only a single fluorophore, recent advances allow close to 20 parallel channels for monitoring different determinants (1)(2)(3)(4). These advances have now surpassed our ability to interpret manually the resulting high-dimensional data and have led to growing interest and recent activity in the development of new computational tools and approaches (5)(6)(7)(8).…”
mentioning
confidence: 99%
“…Further technical details on this experiment and the processing of samples can be found in the Supporting Information of (19). It was observed in (20) that the FL patients can be stratified into two classes that have distinctly different survival outcomes, which is linked to the presence or absence of a subpopulation of B-cells known as the lymphoma negative prognostic (LNP) cells. For our illustration, the dataset is randomly partitioned into a training and test set with equal number of samples in each set.…”
Section: Overview Of the Datasetsmentioning
confidence: 99%